Panbela Therapeutics Inc. (PBLA) Fundamentals

Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.
SHARE INFORMATION
Market Cap$ 5,567,444
Shares Outstanding20,774,045
Float19,686,745
Percent Float94.77%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.89
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions31
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months70,962
Institutional Holdings Percent4.6%
Institutional Sold Previous 3 Months1,687
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent9.9
Insider Sold Previous 3 Months-
Insider Shares Owned2,065,730
TRADING INFO
52 Week High$ 2.40
52 Week Low$ 0.20
52 Week High Change$ -86.60
21 Day Moving Average$ 0.3928
21 Day Extended Moving Average$ 0.420539
50 Day Moving Average$ 0.7786
50 Day Extended Moving Average$ 0.669397
200 Day Moving Average$ 1.4422
200 Day Extended Moving Average$ 1.3908
10 Day Average Volume1,567,914
20 Day Average Volume1,848,476
30 Day Average Volume1,246,728
50 Day Average Volume756,548
Alpha-0.029395
Beta1.2561
Standard Deviation0.289149
R20.051309
7 Day Price Change$ -0.0948
7 Day Percent Change-26.13%
21 Day Price Change$ -0.182
21 Day Percent Change-40.44%
30 Day Price Change$ -0.442
30 Day Percent Change-62.25%
Month to Date Price Change$ -0.0023
Month to Date Percent Change-0.85%
Quarter to Date Price Change$ -0.0023
Quarter to Date Percent Change-0.85%
180 Day Price Change$ -1.83
180 Day Percent Change-87.24%
200 Day Price Change$ -1.62
200 Day Percent Change-85.82%
Year to Date Price Change$ -1.46
Year to Date Percent Change-84.51%

Panbela Therapeutics Inc. (PBLA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.20
Total Debt To Equity0.10
Int Coverage-1,320.50
Current Ratio0.60
Leverage Ratio-11.20
Quick Ratio0.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.10
Enterprise Value$ 9,954,153
Price to Sales0.00
Price to Free Cash-0.50
PE High Last 5 Years-5.00
Price To Book3.30
Price To Cash Flow15.30
PE Low Last 5 Years-2.60
Price to Tangible Book-1.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-484.30
Return on Equity-16,683.39
Return on Capital-426.58

Panbela Therapeutics Inc. (PBLA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorCherry Bekaert LLP
CEOJennifer K Simpson
Emplyoees6
Last AuditUE
CIK0001029125
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address712 Vista Boulevard
Suite 305
Waconia, MN 55387
Websitehttps://www.panbela.com
Facsimile-
Telephone+1 952 479-1196
Email-
Your Recent History
NASDAQ
PBLA
Panbela Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221005 15:40:33